<div id="readability-page-1"><div>                     <p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/med_20260513125620_image.jpeg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="1200" height="670" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/articles/med_20260513125620_image.jpeg"/></p><div><h2>Key Points</h2><ul><li>Interesting insider trades have recently hit three key stocks experiencing very different near-term performance.</li><li>Insiders are purchasing shares of cybersecurity stock Okta, and healthcare giant Abbott.</li><li>Meanwhile, after a historically strong run, Micron's insider selling has increased in Q2.</li></ul></div> <p>Insiders are making moves in three stocks that have seen huge shifts in value over the recent past. This includes insiders buying shares in names that have fallen more than 30% and sales hitting one of the market’s hottest tech stocks. Here are the signals that insiders are sending to investors in Q2.</p> <h2>As AI Fears Weigh on Okta, an Insider Steps In</h2><p>First up is Okta (NASDAQ: OKTA), a stock that has struggled considerably. Compared to its 52-week high, Okta is down almost 40%. One of the key drivers of this is fears regarding the effect that artificial intelligence (AI) will have on the cybersecurity sector.</p> <p>The market is running scared, driven by the idea that AI models will solve many of the problems that cybersecurity companies have built businesses on. However, there is also an argument that when put in the wrong hands, AI models increase cyber risk, potentially making these companies more important than ever.</p> <p>Amid Okta’s struggles, one insider is clearly displaying confidence in the business. In Q2, Director David Schellhase purchased around $267,000 worth of Okta stock, a bullish indicator. Still, investors will notice that insider sales in Q2 have considerably outweighed his purchase, at $1.2 million. However, the details here are interesting.</p> <p>The sales and purchases both came under predetermined 10b5-1 plans. When it comes to 10b5-1 sales, the negative signal they send is somewhat limited, as they are often simply used by insiders to gain liquidity over long periods.</p><hr/><hr/> <p>On the other hand, insiders tend to buy their company’s stock only if they think the price will rise. Thus, 10b5-1 plan buys are still bullish, and potentially even more so than non- 10b5-1 buys. They signal sustained conviction, as future purchases through this plan are likely to occur.</p> <h2>Micron’s Insider Selling: Red Flag or Non-Issue?</h2><p>Micron Technology (NASDAQ: MU) was one of the market's best-performing stocks in 2025 and has continued to move up rapidly in 2026. After notching a 240% gain in 2025, shares have already appreciated more than 170% so far in 2026. The reason for Micron’s rise is well-documented; memory chips are in short supply, while demand from AI data centers is rabid.</p> <p>These dynamics have led to Micron posting some astonishing financial metrics. In its latest quarter, Micron’s revenue rose by 196% year over year (YOY) to a record $23.9 billion. Meanwhile, earnings per share rose by 682% YOY to $12.20.</p> <p>However, the company is also seeing some notable insider activity in Q2. Insider sales have approximately doubled from Q1, up to $45 million versus $22 million last quarter. The company has also not seen any insider buys compared to $7.8 million in buys during Q1.</p> <p>Still, the majority, or $35 million, of these sales came under a 10b5-1 plan. Sumit Sadana’s $10.1 million sale did not. However, Sadana’s sale was a moderate trim rather than an exit, representing around 10% of his holdings. Overall, while not positive, the mitigating factors make Micron’s recent sales not overly concerning.</p> <h2>Abbott Insiders Send Bullish Signals as Shares Plummet in 2026</h2><p>Last up is Abbott Laboratories (NYSE: ABT), one of the world’s largest names in healthcare equipment and supplies. Abbott is another name experiencing weakness, down more than 20% since the start of 2025, and down over 30% in 2026.</p> <p>Abbott’s recent earnings reports were significant contributors to the stock’s decline. In Q4 2025, Abbott posted mixed results, with in-line adjusted earnings per share (EPS) of $1.50 but revenue that fell below expectations by $342 million.</p> <p>The company’s guidance for 2026 was essentially in line with estimates. However, markets focused on the miss, pushing Abbott shares down 10% in reaction. Its Q1 2026 results saw top and bottom-line beats, but Abbott lowered its full-year EPS guidance, leading shares to fall 6%.</p> <p>However, multiple insiders are picking up the slack in this stock, with total insider purchases of $1.13 million in Q2. This adds to buying in Q1, which came in at $1.09 million, and MarketBeat has tracked no insider sales in Q2 thus far.</p> <p>The uptick in purchases clearly coincides with Abbott’s significant 2026 decline, which has been a big drag on longer-term performance. This indicates that insiders are buying what they likely see as a dip in Abbott stock, a positive sign going forward.</p> <h2>Analysts Eye Solid Upside in Abbott Amid 2026 Slide</h2><p>Trades surrounding Micron don’t send a strong signal. However, buys at Okta and Abbott are worth taking notice of. Importantly, investors should remember that insider transactions are just one tool for assessing the future of individual stocks. They are not declarations of how these names will move going forward.</p> <p>Still, Wall Street analysts are echoing the sentiment of insiders when it comes to Abbott. The MarketBeat consensus price target on shares near $119 implies more than 40% upside in the stock. Targets updated after the company’s latest earnings report are similarly bullish. The average of these targets is just slightly lower than the consensus, at approximately $118.</p>                      <div>                         <p>Insider Buying or Selling at Micron Technology?</p>                         <p>Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Micron Technology and related companies.</p>                                                                       </div>                     <h2>Companies in This Article:</h2><table><thead><tr><th>Company</th><th>Current Price</th><th>Price Change</th><th>Dividend Yield</th><th>P/E Ratio</th><th>Consensus Rating</th><th>Consensus Price Target</th></tr></thead><tbody><tr><td>Micron Technology (MU)</td><td>$802.68</td><td>+4.7%</td><td>0.07%</td><td>37.87</td><td>Buy</td><td>$495.63</td></tr><tr><td>Abbott Laboratories (ABT)</td><td>$83.92</td><td>-0.5%</td><td>3.00%</td><td>23.51</td><td>Moderate Buy</td><td>$119.43</td></tr><tr><td>Okta (OKTA)</td><td>$77.99</td><td>-1.4%</td><td>N/A</td><td>59.48</td><td>Moderate Buy</td><td>$100.89</td></tr></tbody></table>                     <div id="author-leo-miller"><p><img src="https://imageproxy.pbkrs.com/https://www.insidertrades.com/logos/authors/small_20240614160247_author-leo-miller.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="141" width="113" original-src="https://imageproxy.pbkrs.com/https://www.insidertrades.com/logos/authors/small_20240614160247_author-leo-miller.jpg"/></p><div><div><h2>About Leo Miller</h2><p>[email protected]</p></div><div><h3>Experience</h3><p>Leo Miller has been a contributing author for InsiderTrades.com since 2024.</p><ul> <li><strong>Professional Background:</strong> Leo Miller is a financial writer with a background in investment research and market analysis. He has held roles as an investment research associate at Laird Norton Wetherby and as a research analyst at Sungarden Investment Publishing, where he gained hands-on experience evaluating equities and portfolio strategies.</li> <li><strong>Credentials:</strong> He holds a Bachelor of Business Administration in Finance from the University of Washington’s Foster School of Business, a top-ranked public business school. He has passed the CFA Level II exam.</li> <li><strong>Finance Experience: </strong>Leo began researching and investing in gold mining stocks in 2019 and started writing about finance and investing in 2021. He joined InsiderTrades.com as a contributing writer in 2024, where he covers both stocks and ETFs. A strong research foundation and direct exposure to financial markets shape his perspectives.</li> <li><strong>Writing Focus:</strong> He specializes in tech stocks, dividend-paying companies, ETFs, and value-oriented opportunities. His work emphasizes clarity, actionable insights, and education for investors at all levels.</li> <li><strong>Investment Approach:</strong> Leo follows a disciplined, long-term investing strategy rooted in fundamental analysis, with a strong focus on economics, sector and industry research, and passive investing principles.</li> <li><strong>Inspiration:</strong> Leo finds the stock market endlessly compelling and enjoys the challenge of separating meaningful data from noise. He’s passionate about analyzing what makes businesses stand out—and sharing those insights to guide informed investment decisions. As he puts it, “Performing strong analysis requires separating the wheat from the chaff.”</li> <li><strong>Fun Fact: </strong>Leo credits his grandfather for sparking his interest in investing and is a lifelong animal lover.</li> <li><strong>Areas of Expertise:</strong> Fundamental analysis, economics, industry and sector analysis</li> </ul> <h3>Education</h3><p>Bachelor in Business Administration, Finance, Foster School of Business at University of Washington</p></div></div></div>                     <div>                         <p>From Our Partners</p><div><div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_20260220101326_pushjb4-before.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="200" height="200" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_20260220101326_pushjb4-before.png"/></p><div><p>SpaceX eyes a 1.75 trillion valuation - here's what to know</p><p>Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...</p><p><span>Brownstone Research</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xODk0OA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xODk0OA"/></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_20260204150656_pushelon-6083103640.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="200" height="200" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_20260204150656_pushelon-6083103640.jpg"/></p><div><p>$30 stock to buy before Starlink goes public (WATCH NOW!)</p><p>In the next 3 minutes…  James Altucher – legendary investor and venture capitalist…  And someone who’s kno...</p><p><span>Paradigm Press</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xODEzNg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xODEzNg"/></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://www.advantagegold.com/wp-content/uploads/2025/05/trump-2-0-1.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="400" height="593" original-src="https://imageproxy.pbkrs.com/https://www.advantagegold.com/wp-content/uploads/2025/05/trump-2-0-1.png"/></p><div><p>Iran's New Leader Just Said Something That Should Terrify Every American</p><p>Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...</p><p><span>American Alternative</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xODkwMg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xODkwMg"/></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_20260420142948_pushiphone-410311640.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="200" height="200" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_20260420142948_pushiphone-410311640.jpg"/></p><div><p>Your book attached</p><p>Your Download Link (Expiring)  If you still haven't downloaded the free Simple Options Trading For Beginners...</p><p><span>Profits Run</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xOTAwNA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xOTAwNA"/></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://assets.stansberryresearch.com/uploads/sites/4/2026/03/Screenshot-2026-03-24-150248-1.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="250" height="250" original-src="https://imageproxy.pbkrs.com/https://assets.stansberryresearch.com/uploads/sites/4/2026/03/Screenshot-2026-03-24-150248-1.png"/></p><div><p>My feud with Zohran Mamdani</p><p>Emmy-winning analyst releases his next big story  Whitney Tilson shocked the nation on 60 Minutes when he ac...</p><p><span>Stansberry Research</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xODU5Mg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xODU5Mg"/></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://files.admin.sovereignsociety.com/images/lies-450.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="450" height="156" original-src="https://imageproxy.pbkrs.com/https://files.admin.sovereignsociety.com/images/lies-450.png"/></p><div><p>Iran War Shock: What I Was Told In That Private Meeting</p><p>You’re Being LIED To About The Iran War  Forget EVERYTHING you’ve heard about the Iran war.  Especially th...</p><p><span>Banyan Hill Publishing</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xODcyOQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xODcyOQ"/></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_20260406130341_pushstock-market-6695489640.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="200" height="200" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_20260406130341_pushstock-market-6695489640.jpg"/></p><div><p>Why this tiny stock may move before the SpaceX IPO drops</p><p>The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...</p><p><span>Behind the Markets</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xODk2Ng?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xODk2Ng"/></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://assets.stansberryresearch.com/uploads/sites/4/2026/04/Picture6.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="250" height="250" original-src="https://imageproxy.pbkrs.com/https://assets.stansberryresearch.com/uploads/sites/4/2026/04/Picture6.png"/></p><div><p>Satellite Images Spot Potential $10 Trillion Discovery</p><p>'Dark Energy': Elon Musk's Next Potential $10 Trillion Move  A highly secure site in West Texas now houses a...</p><p><span>Altimetry</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xOTEwOA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD0xOTEwOA"/></p></div></div></div>                     </div>                 </div></div>

OKTA

<p>Recent insider trading activity has been observed in Okta, Micron Technology, and Abbott Laboratories. Insiders are buying shares of Okta and Abbott, signaling confidence despite their stock declines. Okta's stock is down nearly 40% due to AI concerns, while Abbott has seen a 30% drop in 2026. Conversely, Micron's insiders have increased selling, with $45 million in sales, although most were under a 10b5-1 plan, indicating a lack of immediate concern. Overall, insider purchases in Abbott suggest potential recovery, while Micron's sales raise questions about future performance.</p>

Insider Trades: Okta and Abbott See Buys, Micron Insiders Sell